Advertisement

Skin Lesions and Pressure Ulcers

  • E. Kraft
  • K. Cho
  • John G. HunterEmail author
Living reference work entry

Abstract

The skin is the body’s largest organ and is the most conspicuous. It plays not only an integral role in self-perception and outward attractiveness but very often conveys the earliest diagnostic signs of internal disease. Attention to and care of the skin contribute not only to the elderly patient’s health and physical comfort but also to their quality of life, psychological well-being, and dignity. In this chapter, we review age-related mechanical and functional changes in the skin. The prevalence of skin malignancies and pressure sores is increasing in the growing elderly population. These conditions are often curable, if not preventable, in their early stages. Therefore, caregivers and surgeons must be vigilant for the subtle skin changes inadvertently ignored or neglected by the elderly patient experiencing impaired vision, sensation, mobility, or cognition.

References

  1. 1.
    Burns T, Breathnach S, Cox N, Griffiths C (2004) Rook’s textbook of dermatology. Blackwell Publishing, MaldenCrossRefGoogle Scholar
  2. 2.
    Didierjean L, Gruaz D, Frobert Y, Grassi J, Dayer JM, Saurat JH (1990) Biologically active interleukin 1 in human eccrine sweat: site-dependent variations in alpha/beta ratios and stress-induced increased excretion. Cytokine 2(6):438–446PubMedCrossRefGoogle Scholar
  3. 3.
    Gallo RL (2008) Sounding the alarm: multiple functions of host defense peptides. J Invest Dermatol 128(1):5–6PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Champion RH, Burton JL, Ebling FJG (1992) Rook/Wilkinson/Ebling textbook of dermatology, 5th edn. Blackwell Scientific, OxfordGoogle Scholar
  5. 5.
    Lavker RM, Zheng PS, Dong G (1987) Aged skin: a study by light, transmission electron, and scanning electron microscope. J Invest Dermatol 88:44s–51sPubMedCrossRefGoogle Scholar
  6. 6.
    Richey ML, Richey HK, Fenske NA (1988) Age-related skin changes: development and clinical meaning. Geriatrics 43:49–64PubMedGoogle Scholar
  7. 7.
    Tagami H (2008) Functional characteristics of the stratum corneum in photoaged skin in comparison with those found in intrinsic aging. Arch Dermatol Res 300(Suppl 1):S1–S6PubMedCrossRefGoogle Scholar
  8. 8.
    Gilchrest BA, Blog FB, Szabo G (1979) Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 73:141–143PubMedCrossRefGoogle Scholar
  9. 9.
    Lynch PJ (1994) Dermatology, 3rd edn. Williams & Wilkins, BaltimoreGoogle Scholar
  10. 10.
    Lindelöf B, Sigurgeirsson B, Melander S (1992) Keratoses and cancer. J Am Acad Dermatol 26(6):947–950PubMedCrossRefGoogle Scholar
  11. 11.
    Ortonne JP, Pandya AG, Lui H, Hexsel D (2006) Treatment of solar lentigines. J Am Acad Dermatol 54(5 Suppl 2):S262–S271PubMedCrossRefGoogle Scholar
  12. 12.
    Beacham BE (1992) Common skin tumors in the elderly. Am Fam Physician 46:138–163Google Scholar
  13. 13.
    Banik R, Lubach D (1987) Skin tags: localization and frequencies according to sex and age. Dermatologica 174:180–183PubMedCrossRefGoogle Scholar
  14. 14.
    Mendelson BC, Masson JK (1976) Xanthelasma: follow-up on results after surgical excision. Plast Reconstr Surg 58:535–538PubMedCrossRefGoogle Scholar
  15. 15.
    Eedy DJ (1996) Treatment of xanthelasma by excision with second-ary intention healing. Clin Exp Dermatol 21:273–275PubMedCrossRefGoogle Scholar
  16. 16.
    Borelli C, Kaudewitz P (2001) Xanthelasma palpebrarum: treatment with the erbium: YAG laser. Lasers Surg Med 29(3):260–264PubMedCrossRefGoogle Scholar
  17. 17.
    Basar E, Oguz H, Ozdemir H, Ozkan S, Uslu H (2004) Treatment of xanthelasma palpebrarum with argon laser photocoagulation. Argon laser and xanthelasma palpebrarum. Int Ophthalmol 25(1):9–11PubMedCrossRefGoogle Scholar
  18. 18.
    Fusade T (2008) Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases. Br J Dermatol 158(1):84–87PubMedGoogle Scholar
  19. 19.
    Alster TS, West TB (1996) Ultrapulse CO2 laser ablation of xan-thelasma. J Am Acad Dermatol 24:848–849CrossRefGoogle Scholar
  20. 20.
    Liu HH, Perry HO (1986) Identifying a common – and benign – geriatric lesion. Geriatrics 41(7):71–76PubMedGoogle Scholar
  21. 21.
    Greenbaum SS (1991) The treatment of chondrodermatitis nodularis chronica helicis with injectable collagen. Int J Dermatol 30:291–294PubMedCrossRefGoogle Scholar
  22. 22.
    Moncrieff M, Sassoon EM (2004) Effective treatment of chondrodermatitis nodularis chronica helicis using a conservative approach. Br J Dermatol 150(5):892–894PubMedCrossRefGoogle Scholar
  23. 23.
    Lawrence CM (1991) The treatment of chondrodermatitis nodularis with cartilage removal alone. Arch Dermatol 127:530–535PubMedCrossRefGoogle Scholar
  24. 24.
    Morganroth GS, Leffell DJ (1993) Nonexcisional treatment of benign and premalignant cutaneous lesions. Clin Plast Surg 20:91–104PubMedGoogle Scholar
  25. 25.
    Coldiron BM (1991) The surgical management of chondrodermatitis nodularis chronica helicis. J Dermatol Surg Oncol 17:902–904PubMedCrossRefGoogle Scholar
  26. 26.
    de Ru JA, Lohuis PJ, Saleh HA, Vuyk HD (2002) Treatment of chondrodermatitis nodularis with removal of the underlying cartilage alone: retrospective analysis of experience in 37 lesions. J Laryngol Otol 116(9):677–681PubMedCrossRefGoogle Scholar
  27. 27.
    Ormond P, Collins P (2004) Modified surgical excision for the treatment of chondrodermatitis nodularis. Dermatol Surg 30(2 Pt 1):208–210PubMedGoogle Scholar
  28. 28.
    Taylor MB (1991) Chondrodermatitis nodularis chronica helicis: successful treatment with the carbon dioxide laser. J Dermatol Surg Oncol 17:862–864PubMedCrossRefGoogle Scholar
  29. 29.
    Taylor MB (1992) Chondrodermatitis nodularis chronica helicis. J Dermatol Surg Oncol 18:641CrossRefGoogle Scholar
  30. 30.
    Bekhor PS (2006) Long-pulsed Nd:YAG laser treatment of venous lakes: report of a series of 34 cases. Dermatol Surg 32(9):1151–1154PubMedGoogle Scholar
  31. 31.
    Marks R, Rennie G, Selwood T (1988) The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses. Arch Dermatol 124(7):1039–1042PubMedCrossRefGoogle Scholar
  32. 32.
    Callen JP, Bickers DR, Moy RL (1997) Actinic keratoses. J Am Acad Dermatol 36(4):650–653PubMedCrossRefGoogle Scholar
  33. 33.
    Ackerman AB, Mones JM (2006) Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 155(1):9–22PubMedCrossRefGoogle Scholar
  34. 34.
    Graham G (1993) Advances in cryosurgery during the past decade. Cutis 12:365–372Google Scholar
  35. 35.
    Stockfleth E, Meyer T, Benninghoff B et al (2002) A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratosis. Arch Dermatol 138:1498–1502PubMedCrossRefGoogle Scholar
  36. 36.
    Lebwohl M, Dinehart S, Whiting D et al (2004) Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 50:714–721PubMedCrossRefGoogle Scholar
  37. 37.
    Ulrich C, Bichel J, Euvrard S, Guidi B, Proby CM, van de Kerkhof PC, Amerio P, Rønnevig J, Slade HB, Stockfleth E (2007) Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 157(Suppl 2):25–31PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Stritt A, Merk HF, Braathen LR, von Felbert V (2008) Photodynamic therapy in the treatment of actinic keratosis. Photochem Photobiol 84(2):388–398PubMedCrossRefGoogle Scholar
  39. 39.
    Robinson JK (1989) Actinic cheilitis: a prospective study compar-ing four treatment methods. Arch Otolaryngol Head Neck Surg 115:848–852PubMedCrossRefGoogle Scholar
  40. 40.
    Picascia DD, Robinson JK (1987) Actinic cheilitis: a review of the etiology, differential diagnosis and treatment. J Am Acad Dermatol 17:255–264PubMedCrossRefGoogle Scholar
  41. 41.
    Thappa DM, Garg BR, Tahduea J et al (1997) Cutanous horn: a brief review and report of a case. J Dermatol 24:34–37PubMedCrossRefGoogle Scholar
  42. 42.
    Yu RC, Pryce DW, MacFarlane AW et al (1991) A histopathologi-cal study of 643 cutaneous horns. Br J Dermatol 124:449–452PubMedCrossRefGoogle Scholar
  43. 43.
    Sober AJ, Burnstein JM (1995) Precursors to skin cancer. Cancer 75:645–650PubMedCrossRefGoogle Scholar
  44. 44.
    Micali G, Innocenzi D, Nasca MR, Musumeci ML, Ferraú F, Greco M (1996) Squamous cell carcinoma of the penis. J Am Acad Dermatol 35:432–451PubMedCrossRefGoogle Scholar
  45. 45.
    Morton CA, Whitehurst C, Moseley H et al (1996) Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen’s disease. Br J Dermatol 135:766–771PubMedCrossRefGoogle Scholar
  46. 46.
    Weinstock MA, Sober AJ (1987) The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 116:303–310PubMedCrossRefGoogle Scholar
  47. 47.
    Somach SC, Taira JW, Pitha JV et al (1996) Pigmented lesions in actinically damaged skin. Arch Dermatol 132:1297–1302PubMedCrossRefGoogle Scholar
  48. 48.
    Cohen LM (1995) Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 33:923–936PubMedCrossRefGoogle Scholar
  49. 49.
    Coleman WP, Davis RS, Reed RI et al (1980) Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol 6:476–479PubMedCrossRefGoogle Scholar
  50. 50.
    National Institutes of Health Consensus Conference (1992) Diagnosis and treatment of early melanoma. JAMA 268:1314–1319CrossRefGoogle Scholar
  51. 51.
    Demirci H, Johnson TM, Frueh BR, Musch DC, Fullen DR, Nelson CC (2008) Management of periocular cutaneous melanoma with a staged excision technique and permanent sections the square procedure. Ophthalmology 115(12):2295.e3–2300.e3CrossRefGoogle Scholar
  52. 52.
    Anderson KW, Baker SR, Lowe L, Su L, Johnson TM (2001) Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique. Arch Facial Plast Surg 3(3):202–206PubMedCrossRefGoogle Scholar
  53. 53.
    Huilgol SC, Selva D, Chen C, Hill DC, James CL, Gramp A, Malhotra R (2004) Surgical Margins for Lentigo Maligna and Lentigo Maligna Melanoma: The Technique of Mapped Serial Excision. Arch Dermatol 140(9):1087–1092.  https://doi.org/10.1001/archderm.140.9.1087
  54. 54.
    Temple CL, Arlette JP (2006) Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J Surg Oncol 94(4):287–292PubMedCrossRefGoogle Scholar
  55. 55.
    Cohen LM, McCall MW, Zax RH (1998) Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study. Dermatol Surg 24(6):673–677PubMedCrossRefGoogle Scholar
  56. 56.
    Mahoney MH, Joseph MG, Temple C (2008) Topical imiquimod therapy for lentigo maligna. Ann Plast Surg 61(4):419–424PubMedCrossRefGoogle Scholar
  57. 57.
    Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300PubMedCrossRefGoogle Scholar
  58. 58.
    Jensen P, Hansen S, Møller B et al (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40:177–186PubMedCrossRefGoogle Scholar
  59. 59.
    Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP (1990) Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 49:506–509PubMedCrossRefGoogle Scholar
  60. 60.
    Glogau RG (2000) The risk of progression to invasive disease. J Am Acad Dermatol 42:23–24PubMedCrossRefGoogle Scholar
  61. 61.
    Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP (1998) Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 37:677–681PubMedCrossRefGoogle Scholar
  62. 62.
    Criscione VD, Weinstock MA, Naylor MF et al (2009) Actinic keratoses: natural history and risk of malignant transformation in the veterans affairs topical Tretinoin chemoprevention trial. Cancer 115:2523–2530PubMedCrossRefGoogle Scholar
  63. 63.
    Quaedvlieg PJ, Tirsi E, Thissen MR, Krekels GA (2006) Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol 16:335–339PubMedGoogle Scholar
  64. 64.
    Silverberg N, Silverberg L (1989) Aging and the skin. Postgrad Med 86:131–144PubMedCrossRefGoogle Scholar
  65. 65.
    Kwa RE, Campana K, Moy RL (1992) Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26:1–20PubMedCrossRefGoogle Scholar
  66. 66.
    Proper SA, Rose PT, Fenske NA (1990) Non-melanomatous skin cancer in the elderly: diagnosis and management. Geriatrics 45:57–65PubMedGoogle Scholar
  67. 67.
    Lippman SM, Meyskens FL (1987) Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 107:494–501CrossRefGoogle Scholar
  68. 68.
    Ross AS, Schmults CD (2006) Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 32:1309–1321PubMedGoogle Scholar
  69. 69.
    Schwartz RA (1994) Keratoacanthoma. J Am Acad Dermatol 30:1–19PubMedCrossRefGoogle Scholar
  70. 70.
    Hodak E, Jones RE, Akerman AB (1993) Solitary keratoacanthoma is a squamous cell carcinoma: three examples with metastases. Am J Dermatopathol 15:332–342PubMedCrossRefGoogle Scholar
  71. 71.
    von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10(6):1043–1060CrossRefGoogle Scholar
  72. 72.
    Gloster HM, Brodland DF (1996) The epidemiology of skin cancer. Dermatol Surg 22:217–226PubMedGoogle Scholar
  73. 73.
    Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS (1992) Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 18:471–476PubMedCrossRefGoogle Scholar
  74. 74.
    Wolf DJ, Zitelli JA (1987) Surgical margins for basal cell carcinoma. Arch Dermatol 123:340–344PubMedCrossRefGoogle Scholar
  75. 75.
    Keller KL, Fenske NA, Glass LF (1997) Cancer in the older patient. Clin Geriatr Med 13:339–361PubMedCrossRefGoogle Scholar
  76. 76.
    Mosterd K, Krekels GA, Nieman FH et al (2008) Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol 9:1149–1156PubMedCrossRefGoogle Scholar
  77. 77.
    Gross K, Kircik L, Kricorian G (2007) 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 33(4):433–439PubMedGoogle Scholar
  78. 78.
    Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Maus J, Munzel U (2008) Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 18(6):677–682PubMedGoogle Scholar
  79. 79.
    Rowe DE, Carroll RJ, Day CL Jr (1989) Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15:315–328PubMedCrossRefGoogle Scholar
  80. 80.
    Jemal A, Devesa SS, Hartge P, Tucker MA (2001) Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93(9):678–683PubMedCrossRefGoogle Scholar
  81. 81.
    “Melanoma: Statistics.” Cancer.Net, American Society of Clinical Oncology, 3 Apr. 2018., www.cancer.net/cancer-types/melanoma/statistics
  82. 82.
    Mackie RM, Young D (1984) Human malignant melanoma. Int J Dermatol 23:433–443PubMedCrossRefGoogle Scholar
  83. 83.
    Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36):6199–6206PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C (2008) Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 112(8):1795–1804PubMedCrossRefGoogle Scholar
  85. 85.
    Thomas JM, Newton-Bishop J, A’Hern R et al (2004) Excision margins in high-risk malignant melanoma. N Engl J Med 350:757–766PubMedCrossRefGoogle Scholar
  86. 86.
    Veronesi U, Cascinelli N (1991) Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg 126:438–441PubMedCrossRefGoogle Scholar
  87. 87.
    Veronesi U, Cascinelli N, Adamus J et al (1988) Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med 318:1159–1162PubMedCrossRefGoogle Scholar
  88. 88.
    Khayat D, Rixe O, Martin G et al (2003) Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer 97:1941–1946PubMedCrossRefGoogle Scholar
  89. 89.
    Cohn-Cedermark G, Rutqvist LE, Andersson R et al (2000) Long term results of a randomized study by the Swedish melanoma study group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 89:1495–1501PubMedCrossRefGoogle Scholar
  90. 90.
    Balch CM, Soong SJ, Smith T et al (2001) Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 8:101–108PubMedGoogle Scholar
  91. 91.
    Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA (1996) Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 3:446–452PubMedCrossRefGoogle Scholar
  92. 92.
    Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ, MSLT Group (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355(13):1307–1317; erratum in: N Engl J Med 2006 355(18):1944PubMedCrossRefGoogle Scholar
  93. 93.
    Jack A, Boyes C, Aydin N, Alam K, Wallack M (2006) The treat-ment of melanoma with an emphasis on immunotherapeutic strategies. Surg Oncol 15(1):13–24PubMedCrossRefGoogle Scholar
  94. 94.
    Fang L, Lonsdorf AS, Hwang ST (2008) Immunotherapy for advanced melanoma. J Invest Dermatol 128(11):2596–2605PubMedCrossRefGoogle Scholar
  95. 95.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Geel AN, Eggermont AM, Kroon BB (2002) Safety and efficacy of isolated limb perfusion in elderly melanoma patients. Ann Surg Oncol 9(10):968–974PubMedCrossRefGoogle Scholar
  96. 96.
    Quan W Jr, Ramirez M, Taylor C, Quan F, Vinogradov M, Walker P (2005) Administration of high-dose continuous infusion inter leukin-2 to patients age 70 or over. Cancer Biother Radiopharm 20(1):11–15PubMedCrossRefGoogle Scholar
  97. 97.
    Bernstein SC, Brodland DG (1995) Melanoma in the geriatric patient. J Geriatr Dermatol 3:271–279Google Scholar
  98. 98.
    Fish FS (1996) Soft tissue sarcomas in dermatology. Dermatol Surg 22:268–273PubMedGoogle Scholar
  99. 99.
    Davis JL, Randle HW, Zalla MJ et al (1997) A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 23:105–110PubMedGoogle Scholar
  100. 100.
    Huether MJ, Zitelli JA, Brodland DG (2001) Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 44(4):656–659PubMedCrossRefGoogle Scholar
  101. 101.
    Ratner D, Nelson BR, Brown MD et al (1993) Merkel cell carcinoma. J Am Acad Dermatol 29:143–156PubMedCrossRefGoogle Scholar
  102. 102.
    Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG (2005) Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 23:2300–2309PubMedCrossRefGoogle Scholar
  103. 103.
    Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS (2004) Treatment of Merkel cell carcinoma. Am J Clin Oncol 27:510–515PubMedCrossRefGoogle Scholar
  104. 104.
    McAfee WJ, Morris CG, Mendenhall CM, Werning JW, Mendenhall NP, Mendenhall WM (2005) Merkel cell carcinoma: treatment and outcomes. Cancer 104:1761–1764PubMedCrossRefGoogle Scholar
  105. 105.
    Whittington KT, Briones R (2004) National prevalence and incidence study: 6-year sequential acute care data. Adv Skin Wound Care 17(9):490–494PubMedCrossRefGoogle Scholar
  106. 106.
    Lindan O, Greenway RM, Piazza JM (1965) Pressure distribution on the surface of the human body. I. Evaluation in lying and sitting positions using a “bed of springs and nails”. Arch Phys Med Rehabil 46:378–385PubMedGoogle Scholar
  107. 107.
    Kosiak M (1959) Etiology and pathology of ischemic ulcers. Arch Phys Med Rehabil 40(2):62–69PubMedGoogle Scholar
  108. 108.
    Dinsdale SM (1974) Decubitus ulcers: role of pressure and friction in causation. Arch Phys Med Rehabil 55:147–152PubMedGoogle Scholar
  109. 109.
    Russo A, Steiner C, Spector W Hospitalizations related to pressure ulcers among adults 18 years and older, 2006. Agency for Healthcare Research and Quality, Rockville. Available at http://www.hcup-us.ahrq.gov/reports/statbriefs/sb64.jsp
  110. 110.
    Guralnik JM, Harris TB, White LR, Cornoni-Huntley JC (1988) Occurrence and predictors of pressure sores in the National Health and Nutrition Examination survey follow-up. J Am Geriatr Soc 36(9):807–812PubMedCrossRefGoogle Scholar
  111. 111.
    Berlowitz DR, Brandeis GH, Anderson J, Du W, Brand H (1997) Effect of pressure ulcers on the survival of long-term care residents. J Gerontol A Biol Sci Med Sci 52(2):M106–M110PubMedCrossRefGoogle Scholar
  112. 112.
    Janis JE, Kenkel JM (2003) Pressure sores. Sel Read Plast Surg 9:1–42Google Scholar
  113. 113.
    Berlowitz D, VanDeusen Lukas C, Parker V et al Preventing pressure ulcers in hospitals: a tool kit for improving quality of care. Agency for Healthcare Research and Quality, Rockville. Available at http://www.ahrq.gov/research/ltc/pressureulcertoolkit/
  114. 114.
    Bates-Jensen BM, McCreath HE, Kono A, Apeles NC, Alessi C (2007) Subepidermal moisture predicts erythema and stage 1 pressure ulcers in nursing home residents: a pilot study. J Am Geriatr Soc 55(8):1199–1205PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Schnelle JF, Adamson GM, Cruise PA et al (1997) Skin disorders and moisture in incontinent nursing home residents: intervention implications. J Am Geriatr Soc 45(10):1182–1188PubMedCrossRefGoogle Scholar
  116. 116.
    Tchanque-Fossuo CN, Kuzon WM Jr (2011) An evidence-based approach to pressure sores. Plast Reconstr Surg 127:932–939PubMedCrossRefGoogle Scholar
  117. 117.
    Desai H (1997) Ageing and wounds. Part 2: healing in old age. J Wound Care 6(5):237–239PubMedCrossRefGoogle Scholar
  118. 118.
    Bergstrom N, Braden B (1992) A prospective study of pressure sore risk among institutionalized elderly. J Am Geriatr Soc 40(8):747–758PubMedCrossRefGoogle Scholar
  119. 119.
    Reichel SM (1958) Shearing force as a factor in decubitus ulcers in paraplegics. J Am Med Assoc 166(7):762–763PubMedCrossRefGoogle Scholar
  120. 120.
    Thomas DR, Goode PS, Tarquine PH, Allman RM (1996) Hospital-acquired pressure ulcers and risk of death. J Am Geriatr Soc 44(12):1435–1440PubMedCrossRefGoogle Scholar
  121. 121.
    Langemo D, Anderson J, Hanson D, Hunter S, Thompson P, Posthauer ME (2006) Nutritional considerations in wound care. Adv Skin Wound Care 19(6):297–298, 300, 303PubMedCrossRefGoogle Scholar
  122. 122.
    Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Lopez-Medina IM, Alvarez-Nieto C (2006) Risk assessment scales for pressure ulcer prevention: a systematic review. J Adv Nurs 54(1):94–110PubMedCrossRefGoogle Scholar
  123. 123.
    Barth P, Le K, Madsen B, et al (1984) Pressure profiles in deep tissue. In: Proceedings of the 37th annual conference in engineering in medicine and biology. Los AngelesGoogle Scholar
  124. 124.
    National Pressure Sore Advisory Panel (NPUAP). Pressure Ulcer Stages/Categories 2007. Available at http://www.npuap.org/resources/educational-and-clinical-resources/npuap-pressure-ulcer-stagescategories/
  125. 125.
    Pressure Ulcer Stages Revised by NPUAP. http://www.npuap.org/ pr2.htm. Accessed 18 Jan 2009
  126. 126.
    Healy B, Freedman A (2006) Infections. BMJ 332(7545):838–841PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Capitano B, Leshem OA, Nightingale CH, Nicolau DP (2003) Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility. J Am Geriatr Soc 51(1):10–16PubMedCrossRefGoogle Scholar
  128. 128.
    McInnes E, Bell-Syer SE, Dumville JC, Legood R, Cullum NA (2008) Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev 4:CD001735Google Scholar
  129. 129.
    Stratton RJ, Ek AC, Engfer M et al (2005) Enteral nutritional sup-port in prevention and treatment of pressure ulcers: a systematic review and meta-analysis. Ageing Res Rev 4(3):422–450PubMedCrossRefGoogle Scholar
  130. 130.
    Bourdel-Marchasson I (2000) Nutritional supplementation in elderly people during the course of catabolic illnesses. J Nutr Health Aging 4(1):28–30PubMedGoogle Scholar
  131. 131.
    Ubbink DT, Westerbos SJ, Evans D et al (2008) Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev 3:CD001898Google Scholar
  132. 132.
    Bergstrom N, Horn SD, Smout RJ et al (2005) The National Pressure Ulcer Long-Term Care Study: outcomes of pressure ulcer treatments in long-term care. J Am Geriatr Soc 53:1721–1729PubMedCrossRefGoogle Scholar
  133. 133.
    Ramirez OM, Swartz WM, Futrell JW (1987) The gluteus maximus muscle: experimental and clinical considerations relevant to reconstruction in ambulatory patients. Br J Plast Surg 40(1):1–10PubMedCrossRefGoogle Scholar
  134. 134.
    Sameem M, Au M, Wood T et al (2012) A systematic review of complication and recurrence rates of musculocutaneous, fasciocutaneous, and perforator-based flaps for treatment of pressure sores. Plast Reconstr Surg 67e:130Google Scholar
  135. 135.
    McCarthy V, Lobay G, Matthey PW (2003) Epidural anesthesia as a technique to control spasticity after surgery in a patient with spinal cord injury. Plast Reconstr Surg 112(6):1729–1730PubMedCrossRefGoogle Scholar
  136. 136.
    Keys KA, Daniali LN, Warner KJ et al (2010) Multivariate predictors of failure after flap coverage of pressure ulcers. Plast Reconstr Surg 125:1725–1734PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Weill Cornell Medical CollegeNew York CityUSA
  2. 2.Department of SurgeryNew York-Presbyterian Brooklyn Methodist HospitalNew York CityUSA

Section editors and affiliations

  • Jason Johanning
    • 1
  • Sandhya Lagoo-Deenadayalan
    • 2
  1. 1.Department of SurgeryUniversity of Nebraska Medical CenterOmahaUSA
  2. 2.Duke MedicineDurhamUSA

Personalised recommendations